X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Sun Pharma Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Quarterly Results   (SUNP)

Here are the latest quarterly results of Sun Pharma. For more details, see the Sun Pharma financial fact sheet and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Sun Pharma Quarterly Results

No. of Mths
Qtr. Ending
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
3
Jun-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m82,65179,12771,37062,08866,50366,53269,77172,242 
Other income Rs m1,1941,2222,2451,5202,5481,2923,0281,998 
Turnover Rs m83,84580,34873,61563,60869,05267,82472,79974,239 
Expenses Rs m50,97454,59555,89551,13152,74751,99952,93656,175 
Gross profit Rs m29,14924,53115,8851,45213,75614,53416,83516,067 
Depreciation Rs m3,0383,0683,3823,4663,5873,3934,5524,016 
Interest Rs m5371,6654501,0941,5749531,5541,309 
Profit before tax Rs m26,76821,02014,299-1,58911,14411,47913,75612,739 
Tax Rs m4,4173,7294431,6181,1147,487-1,7671,639 
Profit after tax Rs m22,35117,29113,856-3,20710,0303,99215,52311,101 
Gross profit margin %35.331.022.32.320.721.824.122.2 
Effective tax rate %16.517.73.1-101.810.065.2-12.812.9 
Net profit margin %27.021.919.4-5.215.16.022.215.4 
Diluted EPS Rs 9.3 7.2 5.8 -1.3 4.2 1.7 6.4 4.6  
Diluted EPS (TTM) Rs 30.7 32.0 30.7 20.9 15.8 10.3 10.9 16.9  
 Subscriber Feature View View View View View        
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Sun Pharma 1QFY19 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   UNICHEM LAB  STRIDES SHASUN LTD  MERCK LTD  AJANTA PHARMA  SHASUN PHARMA  

Compare SUN PHARMA With:   UNICHEM LAB  STRIDES SHASUN LTD  MERCK LTD  AJANTA PHARMA  SHASUN PHARMA  

Compare SUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Close at Record Highs; Energy and Metal Stocks Witness Buying(Closing)

Indian share markets continued their momentum during closing hours of trade and ended the day at their fresh record high levels.

Views on news

SUN PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 446.1% (Quarterly Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

For the quarter ended June 2018, SUN PHARMA has posted a net profit of Rs 11 bn (up 446.1% YoY). Sales on the other hand came in at Rs 72 bn (up 16.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 12.0% (Quarterly Result Update)

May 28, 2018 | Updated on May 28, 2018

For the quarter ended March 2018, SUN PHARMA has posted a net profit of Rs 16 bn (up 12.0% YoY). Sales on the other hand came in at Rs 70 bn (down 2.2% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

This is a Must-Have Stock for Your Portfolio(The 5 Minute Wrapup)

Aug 8, 2018

Tanushree just released the permanent wealth blueprint report. This report includes three safe and steady stocks. I like one in particular. Here's why

Trading in These Times: 8% Gains in 3 Days!(Profit Hunter)

Aug 9, 2018

Here are 2 stocks you can buy right now! And there are plenty more opportunities to come...

Only on WhatsApp, a Weaker Rupee Means a Weaker India(Vivek Kaul's Diary)

Aug 16, 2018

While dollar crossing Rs 70 will have its repercussions, the world isn't exactly coming to an end.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

HDFC AMC Makes 65% Listing Gains! Should It Attract Mutual Fund Investors?(Outside View)

Aug 8, 2018

PersonalFN explains if investors should invest in schemes of HDFC Mutual Fund looking at the listing gains of HDFC AMC.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Aug 20, 2018 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

COMPARE SUN PHARMA WITH

MARKET STATS